World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
70
Citations
16904
World Ranking
7026
National Ranking
3234

Richard S. Geary publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Richard S. Geary sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 171 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Richard S. Geary D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Richard S. Geary sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 70 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Richard S. Geary is affiliated with Ionis Pharmaceuticals in the United States. Their work spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a primary focus on molecular biology and cardiovascular and metabolic diseases.

The scientist's research covers various subfields including Molecular Biology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Genetics, and Surgery. Their main topics of work involve:

  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • RNA Interference and Gene Delivery
  • DNA and Nucleic Acid Chemistry
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Advanced biosensing and bioanalysis techniques
  • Lipid metabolism and disorders
  • Lipoproteins and Cardiovascular Health

Frequent publication venues for the scientist include:

  • Nucleic Acid Therapeutics
  • Journal of the American Society of Nephrology
  • European Heart Journal
  • New England Journal of Medicine
  • Circulation

Frequent co-authors collaborating with Richard S. Geary include:

  • Sotirios Tsimikas
  • Eugene Schneider
  • Brett P. Monia
  • Sanjay Bhanot
  • Rosie Z. Yu

Recent notable papers authored or co-authored by Richard S. Geary are:

  • Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia, 2020, European Heart Journal
  • Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk, 2021, European Heart Journal
  • An oral antisense oligonucleotide for PCSK9 inhibition, 2021, Science Translational Medicine
  • Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial, 2020, The Lancet Gastroenterology & Hepatology
  • Antisense drug discovery and development technology considered in a pharmacological context, 2020, Biochemical Pharmacology

Best Publications

  • Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides.

    Richard S. Geary;Daniel Norris;Rosie Yu;C. Frank Bennett

  • Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials

    Nicholas J Viney;Julian C van Capelleveen;Richard S Geary;Shuting Xia

  • Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides

    Mark J. Graham;Richard G. Lee;Teresa A. Brandt;Li-Jung Tai

  • Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study

    Sotirios Tsimikas;Sotirios Tsimikas;Nicholas J Viney;Steven G Hughes;Walter Singleton

  • Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia

    Daniel Gaudet;Veronica J. Alexander;Brenda F. Baker;Diane Brisson

  • Targeting APOC3 in the Familial Chylomicronemia Syndrome

    Daniel Gaudet;Diane Brisson;Karine Tremblay;Veronica J. Alexander

  • Volanesorsen and triglyceride levels in familial chylomicronemia syndrome

    Joseph L Witztum;Daniel Gaudet;Steven D Freedman;Veronica J Alexander

  • Pharmacology of Antisense Drugs

    C. Frank Bennett;Brenda F. Baker;Nguyen Pham;Eric Swayze

  • Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans

    Mark J. Graham;Richard G. Lee;Thomas A. Bell;Wuxia Fu

  • Pharmacokinetic Properties of 2′-O-(2-Methoxyethyl)-Modified Oligonucleotide Analogs in Rats

    Richard S. Geary;Tanya A. Watanabe;LoAnne Truong;Sue Freier

  • Antisense oligonucleotide pharmacokinetics and metabolism.

    Richard S Geary

  • Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100

    Rosie Z. Yu;Tae-Won Kim;An Hong;Tanya A. Watanabe

  • Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial

    Maartje E. Visser;Gilbert Wagener;Brenda F. Baker;Richard S. Geary

  • Phase I study of an antisense oligonucleotide to protein kinase C-alpha (ISIS 3521/CGP 64128A) in patients with cancer.

    Yuen Ar;Halsey J;Fisher Ga;Holmlund Jt

  • Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia.

    Daniel Gaudet;Ewa Karwatowska-Prokopczuk;Seth J Baum;Eunju Hurh

  • Phase I Evaluation of ISIS 3521, an Antisense Oligodeoxynucleotide to Protein Kinase C-Alpha, in Patients With Advanced Cancer

    J. Nemunaitis;J. T. Holmlund;M. Kraynak;D. Richards

  • Clinical pharmacological properties of mipomersen (Kynamro), a second generation antisense inhibitor of apolipoprotein B.

    Stanley T. Crooke;Richard S. Geary

  • Compounds and methods for modulating gene expression

    Sanjay Bhanot;Richard S. Geary;Robert Mckay;Brett P. Monia

  • Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides.

    R S Geary;R Z Yu;A A Levin

  • Fomivirsen: clinical pharmacology and potential drug interactions.

    Richard S. Geary;Scott P. Henry;Lisa R. Grillone

Frequent Co-Authors

Sotirios Tsimikas
Sotirios Tsimikas University of California, San Diego
Rosanne M. Crooke
Rosanne M. Crooke Ionis Pharmaceuticals (United States)
Eric E. Swayze
Eric E. Swayze Ionis Pharmaceuticals (United States)
Brett P. Monia
Brett P. Monia Ionis Pharmaceuticals (United States)
Punit P. Seth
Punit P. Seth Ionis Pharmaceuticals (United States)
Joseph L. Witztum
Joseph L. Witztum University of California, San Diego
Stanley T. Crooke
Stanley T. Crooke Ionis Pharmaceuticals (United States)
Daniel Gaudet
Daniel Gaudet University of Montreal
Erik S.G. Stroes
Erik S.G. Stroes University of Amsterdam
John J.P. Kastelein
John J.P. Kastelein University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry can lead to diverse healthcare careers. Many students are choosing online programs for flexibility and affordability. For example, those interested in nutrition can review the cost of masters degree in nutrition to compare schools and find affordable options.

The medical imaging sector is another in-demand pathway. With the rise of ultrasound tech school online programs, it's easier than ever to train for roles like diagnostic medical sonographer without attending traditional classes. Many programs cater to working professionals, letting you balance study and work.

If you're drawn to radiology, consider enrolling in accelerated radiology tech programs online. These programs provide a fast-track to certification and entry-level positions in healthcare imaging.

Dietetics is a growing career for those passionate about health and nutrition science. Specialized dietetic masters programs offer advanced training to help graduates stand out in clinical, community, and food service settings.

Whether you're starting your career or upskilling, online degrees open new doors to exciting biology and healthcare roles.

Best Scientists Citing Richard S. Geary

Trending Scientists

Recently Published Articles